AAAAAA
Results:
1-21
|
Results: 21
Authors:
BLANQUE R
PAYSANT J
VASSE M
SORIA C
SORIA J
GARDNER CR
Citation: R. Blanque et al., EXPRESSION AND RELEASE OF THE IL6 RECEPTOR IN DIFFERENT CELL-TYPES, European cytokine network, 9(3), 1998, pp. 26-26
Authors:
LEVEQUE C
GRAFTE S
PAYSANT J
SOUTIF A
LENORMAND B
VASSE M
SORIA C
VANNIER JP
Citation: C. Leveque et al., REGULATION OF INTERLEUKIN-3 RECEPTOR-ALPHA CHAIN (IL-3R-ALPHA) ON HUMAN MONOCYTES BY INTERLEUKIN (IL)-4, IL-10, IL-13, AND TRANSFORMING-GROWTH-FACTOR-BETA (TGF-BETA), Cytokine (Philadelphia, Pa. Print), 10(7), 1998, pp. 487-494
Authors:
POURTAU J
SORIA C
PAYSANT J
VANNIER JP
VASSE M
Citation: J. Pourtau et al., IN-VITRO EFFECT OF ONCOSTATIN-M ON THE RELEASE BY ENDOTHELIAL-CELLS OF VON-WILLEBRAND-FACTOR, TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1, Blood coagulation & fibrinolysis, 9(7), 1998, pp. 609-615
Authors:
GRAFTE S
LEVEQUE C
PAYSANT J
VASSE M
SORIA C
VANNIER JP
Citation: S. Grafte et al., IL-12 INDIRECTLY ENHANCES PROLIFERATION OF 5-FU-TREATED HUMAN HEMATOPOIETIC PERIPHERAL-BLOOD CD34(+) CELLS, American journal of hematology, 58(3), 1998, pp. 183-188
Authors:
PAYSANT J
VASSE M
SORIA J
LENORMAND B
POURTAU J
VANNIER JP
SORIA C
Citation: J. Paysant et al., REGULATION OF THE UPAR UPA SYSTEM EXPRESSED ON MONOCYTES BY THE DEACTIVATING CYTOKINES, IL-4, IL-10 AND IL-13 - CONSEQUENCES ON CELL-ADHESION TO VITRONECTIN AND FIBRINOGEN/, British Journal of Haematology, 100(1), 1998, pp. 45-51
Authors:
VASSE M
VANDREDEN P
THUILLIER N
BOUYE M
VANNIER JP
Citation: M. Vasse et al., A NEW CHRONOMETRIC ASSAY BASED ON THE VA-DEPENDENT PROCOAGULANT ACTIVITY OF A SNAKE-VENOM FOR THE DETECTION OF FACTOR-V-LEIDEN, Thrombosis and haemostasis, 1997, pp. 80-80
Authors:
BORG JY
YASTREMSKY F
DESHAYES A
TOULLEC J
CHRETIEN MH
VASSE M
SALADINTHIRON C
FREBOURG T
Citation: Jy. Borg et al., RELIABLE IDENTIFICATION OF FACTOR-V-LEIDEN INDIVIDUALS BY MODIFIED APC RESISTANCE TESTS, Thrombosis and haemostasis, 1997, pp. 82-82
Authors:
PAYSANT J
VASSE M
POURTAU J
LENORMAND B
VANNIER JP
SORIA J
SORIA C
Citation: J. Paysant et al., EFFECT OF DEACTIVATING CYTOKINES ON UROKINASE AND UROKINASE RECEPTOR EXPRESSION ON MONOCYTES - POSSIBLE ACTION ON CELL-ADHESION, Thrombosis and haemostasis, 1997, pp. 454-454
Authors:
CAILLEUX N
GUEGANMASSARDIER E
BORG JY
VASSE M
MIHOUT B
WATELET J
LEVESQUE H
COURTOIS H
Citation: N. Cailleux et al., PSEUDOTHROMBOANGIITIS OBLITERANS AND QUAL ITATIVE PROTEIN-C DEFECT - A CASE-REPORT, Journal des maladies vasculaires, 21(1), 1996, pp. 47-49
Authors:
DUCHEMIN J
BORG JY
BORGEL D
VASSE M
LEVEQUE H
AIACH M
GANDRILLE S
Citation: J. Duchemin et al., 5 NOVEL MUTATIONS OF THE PROTEIN-S ACTIVE GENE (PROS-1) IN 8 NORMAN FAMILIES, Thrombosis and haemostasis, 75(3), 1996, pp. 437-444
Authors:
VASSE M
PAYSANT J
SORIA J
COLLET JP
VANNIER JP
SORIA C
Citation: M. Vasse et al., REGULATION OF FIBRINOGEN BIOSYNTHESIS BY CYTOKINES, CONSEQUENCES ON THE VASCULAR RISK, Haemostasis, 26, 1996, pp. 331-339
Authors:
VASSE M
PAYSANT J
SORIA J
MIRSHAHI SS
VANNIER JP
SORIA C
Citation: M. Vasse et al., DOWN-REGULATION OF FIBRINOGEN BIOSYNTHESIS BY IL-4, IL-10 AND IL-13, British Journal of Haematology, 93(4), 1996, pp. 955-961
Authors:
VASSE M
GAUCHER C
BEUFE S
VANDREDEN P
MONCONDUIT M
MAZURIER C
BORG JY
SORIA C
Citation: M. Vasse et al., ANALYSIS OF FACTOR-VIII IN A FAMILY WITH INHERITED RESISTANCE TO ACTIVATED PROTEIN-C WITHOUT FACTOR-V LEYDEN, Thrombosis and haemostasis, 73(6), 1995, pp. 1369-1369
Authors:
BEUFE S
BORG JY
VASSE M
CHARBONNIER F
MOREAU V
MONCONDUIT M
FREBOURG T
Citation: S. Beufe et al., CO-SEGREGATION OF THROMBOSIS WITH THE FACTOR-V Q506 MUTATION IN AN EXTENDED FAMILY WITH RESISTANCE TO ACTIVATED PROTEIN-C, British Journal of Haematology, 89(3), 1995, pp. 659-662
Authors:
VASSE M
LEDUC O
BORG JY
CHRETIEN MH
MONCONDUIT M
Citation: M. Vasse et al., RESISTANCE TO ACTIVATED PROTEIN-C - EVALUATION OF 3 FUNCTIONAL ASSAYS, Thrombosis research, 76(1), 1994, pp. 47-59
Authors:
VASSE M
COLLET JP
SORIA J
MIRSHAHI SS
VANNIER JP
SORIA C
Citation: M. Vasse et al., FIBRINOGEN, A VASCULAR RISK FACTOR - A SIMPLE MARKER OR A REAL CAUSE OF VASCULAR LESION, Thrombosis research, 75(3), 1994, pp. 349-352
Authors:
COLLET JP
MISHAL Z
VASSE M
MIRSHAHI M
CAEN JP
SORIA C
SORIA J
Citation: Jp. Collet et al., PHARMACOLOGICAL APPROACHES OF FIBRIN GEL ARCHITECTURE MODULATION AND THROMBUS DEGRADATION - ITS IMPLICATION IN ATHEROGENESIS AND THROMBOEMBOLISM DISEASE, Thrombosis research, 75(3), 1994, pp. 353-359
Authors:
BORG JY
VASSE M
LEVESQUE H
QUEDINEL V
ARZUR C
DALIPHARD S
CHRETIEN MH
DUCLOS M
THIRON C
Citation: Jy. Borg et al., LONG-TERM MANAGEMENT OF ORAL ANTICOAGULANT-THERAPY IN CONGENITAL QUANTITATIVE PROTEIN-S OR PROTEIN-C DEFICIENCY USING BIOLOGICAL PRETHROMBOTIC MARKERS, Thrombosis and haemostasis, 69(6), 1993, pp. 898-898
Authors:
BORG JY
LEVESQUE H
VASSE M
DALIPHARD S
CAILLEUX N
MONCONDUIT M
COURTOIS H
Citation: Jy. Borg et al., ACQUIRED VON-WILLEBRAND SYNDROME DURING HYPOTHYROIDISM - EFFECTS OF THYROXINE TREATMENT ON VON-WILLEBRAND-FACTOR AND FIBRINOLYSIS PARAMETERS, Thrombosis and haemostasis, 69(6), 1993, pp. 1180-1180
Authors:
BORG JY
CHRETIEN MH
DOUCET J
BERCOFF E
CHEMINOT N
AZOULAY S
VASSE M
CHRETIEN P
Citation: Jy. Borg et al., PHARMACOKINETIC AND HEMOSTATIC EFFECTS OF DERMATAN SULFATE (DS, MEDIOLANUM-PHARMACEUTICI) ADMINISTERED BY INTRAVENOUS-INFUSION IN ELDERLY VOLUNTEERS, Thrombosis and haemostasis, 69(6), 1993, pp. 1320-1320
Authors:
LEVESQUE H
BORG JY
CAILLEUX N
TRON F
VASSE M
MEJJAD O
OMNIENT Y
DERUMEAUX G
ETIENNE I
MIHOUT B
TESTART J
GODIN M
LELOET X
BRASSEUR G
COURTOIS H
Citation: H. Levesque et al., SIGNS OF ARTERIAL THROMBOSIS IN ANTIPHOSP HOLIPID SYNDROME - REPORT ON 155 CASES, La Revue de medecine interne, 14(6), 1993, pp. 420-420
Risultati:
1-21
|